Colgate-Palmolive has been upgraded to a buy rating due to a return in organic sales growth of 2.4% and strong profitability that leads its sector. The company’s 2026 guidance is nearing its long-term targets, supporting optimism for stock multiple expansions. Despite a relatively high forward price-to-earnings ratio of about 22.7 times, Colgate-Palmolive’s superior EBITDA margins, strong free cash flow, and reliable dividends justify its valuation. Risks remain if organic growth fails to exceed 3%, but if targets are met, investors can expect double-digit total returns.
Five dividend stocks—Procter & Gamble, Johnson & Johnson, Coca-Cola, Colgate-Palmolive, and PepsiCo—have consistently raised their dividends through every U.S. recession since at least 1963. These companies demonstrated resilience during major downtu...
The iShares S&P 100 ETF recently replaced Nike, Colgate-Palmolive, Simon Property Group, and Honeywell with four AI-related tech companies: Dell Technologies, Palo Alto Networks, Arista Networks, and SanDisk. This change reflects the growing market c...
